Objectives-The purpose of this study was to evaluate the diagnostic utility of karyotype analysis of amniotic fluid for fetuses with abnormal sonographic findings and to determine the detection rates of abnormal karyotypes.
Methods-We conducted a retrospective study of 5328 fetuses with abnormal sonographic findings in the first or second trimester enrolled from October 1998 and September 2015. Cytogenetic results from amniotic fluid were obtained in all of these pregnancies. Sonographic abnormalities were stratified according to anatomic system involvement.
Results-A total of 238 abnormal karyotypes were encountered in the 5328 fetuses (4.5%). The highest rate of chromosomal anomalies was in fetuses with structural abnormalities in multiple organ systems (25.7%), followed by an abnormal amniotic fluid volume (7.9%), structural abnormalities in a single system (7.3%), multiple nonstructural anomalies (7.2%), isolated placental abnormalities (7.1%), and isolated soft markers for aneuploidy (2.4%; P < .01). Among abnormalities in a single system, gastrointestinal and neck/body fluids had particularly high detection rates (26.1% and 26.2%, respectively). A detailed analysis suggested that the probability of an abnormal karyotype among every anatomic system was statistically significant (P < .01). This study identified several common indications with extremely high abnormal rates: duodenal atresia (53.1%), holoprosencephaly (48.8%), fetal hydrops (39.5%), cerebellar hypoplasia (32.0%), cystic hygroma (31.5%), absent/short nasal bone (11.0%), and bilateral choroid plexus cysts (8.5%).
Conclusions-Cytogenetic analysis has important clinical utility in a wide range of settings, such as prenatal diagnosis. For fetuses with indications of a highly abnormal detection rate, karyotype analysis should be suggested.
Key Words-abnormal sonographic findings; detection rate; fetuses; karyotype analysis; obstetric ultrasound F or many years, karyotype analysis of amniotic fluid has remained the most common invasive diagnostic procedure for the detection of chromosomal aberrations in fetuses, although genetic amniocentesis carries related risks of miscarriage and pregnancy loss in the range of 0.5% to 1.0%. 1, 2 Conventional cytogenetic analysis allows for the identification of numeric and structural aberrations of the chromosomes, such as aneuploidies and translocations.
These aberrations are usually caused by chromosomal nondisjunction or breakage during the anaphase of cell division, and most chromosomal diseases are manifested as mental retardation or multiple fetal malformations. 2, 3 Karyotype analysis, therefore, is an essential component of the evaluation of the fetus with sonographic abnormalities.
Detection rates for abnormal karyotypes in fetuses with specific sonographic anomalies have been reported previously. These include holoprosencephaly, duodenal atresia, cystic hygroma, micrognathia, exomphalos, abnormalities of fetal growth, choroid plexus cysts, increased nuchal thickening, shortened long bones, an echogenic bowel, and a single umbilical artery. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] The incidence of chromosomal anomalies in these studies ranged from approximately 3.0% to 40.0%, according to the type of malformation. Fetuses with multiple malformations had the highest chromosomal abnormality rate among all types of abnormal sonographic findings. Staebler et al 6 reported detection rates for traditional karyotyping with a stratification of single and multiple sonographic anomalies. However, all of these publications had small sample sizes with abnormal sonographic findings and a limited range of specific malformations.
Also, chromosomal microarray analysis is already being used in many laboratories, replacing or combined with the standard cytogenetic analysis. [14] [15] [16] [17] [18] However, balanced numeric aberrations such as translocations cannot be identified by a microarray analysis. These have been shown to have a 6% increased risk of abnormal outcomes. 19, 20 In addition, low-level mosaicism cannot be detected accurately by a microarray analysis. Therefore, cytogenetic analysis still plays a certain important role in reducing birth defects.
To our knowledge, no large-scale sample study has been reported about the diagnostic utility of karyotype analysis in fetuses with abnormal obstetric sonographic findings until now. In this study, more than 5000 fetuses with abnormal sonographic findings were involved, and we tried to evaluate the diagnostic utility and calculate the detailed detection rates of abnormal karyotypes for many common sonographic indications. Fetuses with abnormal maternal serum screening test results and advanced maternal age were not included. Our data should be helpful for accurate patient counseling given the different combinations of abnormal sonographic findings that can occur in real life.
Materials and Methods
Prenatal patients were recruited at the Shanghai Ji Ai Genetics & IVF Institute between October 1998 and September 2015. All cases included had cytogenetic analyses from second-trimester amniotic fluid (15-20 mL), which was collected by amniocentesis under ultrasound guidance.
A total of more than 40,000 patients were tested for a variety of indications in our laboratory, including 5328 samples with abnormal sonographic findings. All data in the analyses presented here were gathered or generated during the process of routine clinical testing. Fetuses with a family history of a chromosomal rearrangement in a parent were excluded. Pregnancies that were therapeutically terminated because of sonographic anomalies not considered fetal demises were included. At recruitment, written informed consent was obtained from each patient, and our research protocol was approved by the Ethics Committee for Human Subject Research of the Obstetrics and Gynecology Hospital, Fudan University.
All cases were reviewed by our physicians and categorized according to the sonographic anomalies identified. These were categorized as follows: (1) structural anomalies in multiple organ systems; (2) structural anomalies limited to a single system; (3) an isolated abnormal amniotic fluid volume; (4) isolated abnormalities of fetal growth; (5) an isolated single soft marker; (6) isolated multiple soft markers; (7) isolated multiple nonstructural anomalies; (8) an isolated placental abnormality; and (9) unspecified defects. In structural anomalies, for study purposes, we included the following findings in our category of nonstructural abnormalities: intrauterine growth restriction, a placental abnormality, soft markers, an abnormal amniotic fluid volume, and multiple additional findings. Also, structural abnormalities in a single system were further categorized according to anatomic system. Each system was comprehensively divided into the commonly seen malformations. Each malformation combined with anomalies in other systems was summarized for calculating detection rates. Cystic hygroma was categorized as a structural anomaly in the abnormal body fluid category, which also included edema, pleural effusions, ascites, and hydrops. Soft markers included an intracardiac echogenic focus, a choroid plexus cysts, an echogenic bowel, an absent/ short nasal bone, a single umbilical artery, a persistent right umbilical vein, short long bones, intraperitoneal echogenicity, an echogenic liver, an increased nuchal fold, and increased nuchal translucency. Every single soft marker combined with structural anomalies or other nonstructural anomalies was also summarized for calculating the detection rate. Ventriculomegaly and posterior fossa defects were categorized as structural anomalies.
Detection rates for fetal anomalies that were seen in fewer than 5 cases were not calculated. The Pearson v 2 or Fisher exact test was used to evaluate possible significant differences in probabilities of abnormal karyotypes according to the categorization. P < .05 was considered significant. Statistical analyses were conducted with Stata version 11.0 software (StataCorp, College Station, TX).
Results
Between 1998 and 2015, 5328 prenatal cases with obstetric sonographic anomalies were received by our laboratory for karyotype analysis of amniotic fluid. Cordocentesis samples were not included. Among structural abnormalities in a single system, 691 cases showed a single anomaly or multiple anomalies in a single system, and 393 had structural anomalies in a single system plus nonstructural anomalies such as abnormal growth and soft markers. Of these cases, 79 (30 1 49 of 691 1 393 [7.3%]) showed clinically important chromosomal aberrations. The categories of gastrointestinal and neck/body fluids had particularly high detection rates (6 of 23 [26. 1%] and 17 of 65 [26.2%] ). The detection rates for genitourinary and respiratory system anomalies were lowest (1.1% and 0.0%). A detailed analysis of each anatomic system suggested that the probability of an abnormal karyotype among every anatomic system was statistically significant (P < .01). The highest detection rate for an isolated single anomaly was seen with holoprosencephaly (83.3%), followed by duodenal atresia (41.7%), fetal hydrops (39.1%), cystic hygroma (25.8%), ascites (22.2%), pleural effusion (21.4%), pericardial effusion (20.0%), and cerebellar hypoplasia (14.3%; Table 2 ).
Among structural abnormalities in multiple systems, 122 cases showed anomalies in multiple systems without nonstructural anomalies, whereas 57 also had nonstructural anomalies. Overall, 46 abnormal karyotypes (25.7%) were identified. The highest detection rates were seen with duodenal atresia (60.0%), holoprosencephaly (42.9%), cleft lip/palate (42.9%), micrognathia (40.0%), fetal hydrops (40.0%), cystic hygroma (35.7%), cerebellar hypoplasia (34.9%), ventricular septal defects (34.2%), and clubfeet or hand contractures (30.8%). The detection rate was significantly higher for cases referred with anomalies in multiple organ systems compared with those with anomalies limited to a single organ system (P < .01; Table 2 ).
Among the isolated nonstructural anomalies, 3197 cases showed a soft sonographic marker; 75 showed an abnormal amniotic fluid volume; 63 showed abnormalities of fetal growth; and 14 showed placental abnormalities. In total, 76 of 3349 (2.3%) were found to have clinically important chromosomal aberrations. Table 3 lists the detection rates of abnormal karyotypes in the cases with isolated nonstructural sonographic findings and cases with isolated nonstructural sonographic findings plus structural anomalies or other nonstructural anomalies. The cases with soft-marker anomalies and abnormalities of growth combined with structural anomalies or other nonstructural anomalies had a higher detection rate than those with isolated anomalies (2.4%; P < .01). Table 5 . Known polymorphisms on chromosomes 1, 9, and 16, were excluded.
Discussion
At present, karyotype analysis is still considered the reference standard and most frequently used method for diagnosis of fetal chromosomal disorders. In this study, the overall prevalence of chromosomal abnormalities was 4.5%, which ranged from 1.6% to 26.2% (Table 1) and was much higher than that seen in cases with Not all cases for each system are represented in its subcategories. In the single-system categories, cases may also have been counted in multiple subcategories if the system included multiple anomalies. In the multiple-system categories, 1 fetus was included in 2 or more systems. DR indicates detection rate. a Including both unilateral and bilateral kidney agenesis.
abnormal maternal serum screening results or advanced maternal age. [4] [5] [6] In other published studies, the rates of chromosomal aneuploidy in fetuses with abnormal sonographic findings ranged from approximately 3.0% to 40% depending on the organ system(s) involved and were similar to the rates reported in our study. [1] [2] [3] [4] [5] [6] 21 In addition to isolated soft markers or nonstructural anomalies, this category also contained those with combined structural anomalies and other nonstructural anomalies.
We confirmed, as in other studies, that fetuses with structural abnormalities carry a considerable risk of chromosomal abnormalities. 6, 22, 23 In addition, the difference between single-and multiple-system abnormalities has been identified previously. 6, 21 For the specific category of a single-system defect, gastrointestinal and neck/body fluids had particularly high detection rates, which were higher when only considering the cases without nonstructural anomalies (Table 1) . Staebler et al 6 previously reported detection rates of an abnormal karyotype with a similar stratification of single-and multiple-system anomalies in 428 fetuses. Their overall detection rates were 9.3% in cases with a single-system malformation and 18.8% with multiple-system malformations, which were consistent with our findings; however, their rates based on the specific anatomic system involved were much higher than ours except gastrointestinal and abdominal wall systems. They also did not present data for some specific malformations, possibly because of the smaller sample size.
Among all structural malformations, a detailed analysis of each anatomic system suggested a high association of chromosomal abnormalities with some specific malformations. For fetuses with duodenal atresia, Takahashi et al 24 and Choudhry et al 25 found that 88% and 55% of these abnormal karyotypes were trisomy 21. Our result revealed that trisomy 21 accounted for 88.2% (15 of 17) of chromosomal abnormalities, which was consistent with those results. In addition, some other reports have suggested that the rates for fetuses with micrognathia 26, 27 were similar to ours: in the range of 20% to 40%. One point that should be mentioned is that we did not see isolated micrognathia cases; all 20 cases had multiple-system anomalies. Also, the detection rates for holoprosencephaly and cystic hygroma were lower in our study than those reported previously, 6, 28, 29 and the detection rates for fetuses with gastroschisis were in the range of 0% to 4%, 6,30,31 whereas our result was higher than that. Maybe the amount of sample sizes and selection biases were the reasons for this difference. In our results, some other specific malformations were also associated with a higher risk of abnormal fetal karyotypes. These included ventriculomegaly, a ventricular or atrial septal defect, a hypoplastic ventricle, cleft lip/ palate, an abnormal stomach, clubfeet or hands, renal sinus separation, and kidney agenesis. In addition, we concluded for most malformations that the detection rate was significantly higher in multiple-system anomalies compared with those limited to a single organ system, as shown in Table 2 .
Among the nonstructural anomalies, the detection rates for increased nuchal translucency and nuchal fold were 16.7% and 2.8%, respectively. These were a little lower than previous reports 6, 32, 33 and ranked first in the proportion of major nonstructural sonographic anomalies. In some studies, the authors concluded that there were no abnormal karyotypes in fetuses with an isolated intracardiac echogenic focus, 10,34 while our rate was 1.1%, and we found that 4 (80.0%) of the abnormal karyotypes were sex chromosomal disorders. Our chromosome abnormality rates for choroid plexus cysts (8.5%) and an absent/short nasal bone (11.0%) were much higher than reported. 11, 35, 36 We also confirmed that bilateral choroid plexus cysts had a higher abnormality rate compared with unilateral choroid plexus cysts (P < .01). In some indications, no chromosomal abnormalities were found at all in our results, including a single umbilical artery, a persistent right umbilical vein, and short long bones, which has been reported previously. 12, 25 The rate of aneuploidy in an isolated echogenic bowel has been reported to range from approximately 3% to 6%. 37, 38 We did not find any chromosomal abnormalities in an isolated echogenic bowel, but the rate was 11.1% (8 of 72) in cases in which an echogenic bowel was combined with structural anomalies. The association between chromosomal abnormalities and an echogenic liver has not been reported previously; however, we identified 3 abnormalities (25%), including 2 trisomy 21 cases and 1 mosaic trisomy 7. In addition, our result for abnormalities of growth was similar to that from Drummond et al. 6 Collectively, most indications when combined with structural anomalies or other nonstructural anomalies had a higher detection rate than those with an isolated anomaly (P < .01). The total detection rate among cases with isolated nonstructural anomalies (2.8%) was significantly lower than the detection rate for multiple anomalies (25.7%) and anomalies in single organ systems (7.3%; P < .01).
One of the limitations of our study was that not all women with these sonographic findings would undergo amniocentesis, which might be relevant from the perspective of a selection bias. The number with unspecified defects was also a limitation.
In summary, our large-scale study confirms the diagnostic utility of karyotype analysis in fetuses with abnormal obstetric sonographic findings and gives detailed detection rates of abnormal karyotypes for common sonographic anomalies. Our results should be helpful for accurate patient counseling given the different combinations of abnormal sonographic findings that can occur in real life. Obviously, there are diverse rates of chromosome abnormalities detected with the current spectrum of sonographic indications. For fetuses with multiplesystem malformations or sonographic findings that indicate an extremely highly abnormal detection rate, such as duodenal atresia, holoprosencephaly, cerebellar hypoplasia, fetal hydrops, cystic hygroma, ascites, pleural effusion, pericardial effusion, an absent/short nasal bone, and bilateral choroid plexus cysts, karyotype analysis should be performed.
